Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans.

CONTEXT Fibroblast growth factor 19 (FGF19) improves glycemic control in diabetic animals and is secreted from the gastrointestinal tract after meals in response to bile acid stimulation. OBJECTIVE We sought to understand how ingestion of carbohydrates, protein or lipids affect both FGF19 and bile acid concentrations in human plasma, with the hypothesis that variation in the bile acid response to different macronutrients would predict differences in plasma FGF19 levels. DESIGN This was a randomized, within-subjects crossover study. SETTING The study was conducted at a university clinical research center. PARTICIPANTS There were 16 healthy human subjects included in the study. INTERVENTIONS Isocaloric, isovolemic beverages composed primarily of carbohydrates, proteins, or lipids were provided to each participant on 3 separate occasions. MAIN OUTCOME MEASURES The magnitudes of postprandial rises of plasma FGF19 and total bile acid levels were determined. RESULTS All beverages induced an initial transient decline of plasma FGF19 levels during the first 60 minutes after consumption. For FGF19, the ingestion of carbohydrate was associated with the fastest and highest increase of plasma levels, returning to baseline at 5 hours. By comparison, the protein beverage induced a modest but significant elevation of FGF19 levels that peaked at the end of the 6-hour sampling interval, whereas a lipid beverage was without effect. In contrast, total bile acid levels increased in plasma only in response to a high-lipid beverage, demonstrating a marked divergence between the FGF19 and bile acid response to lipid vs carbohydrate. CONCLUSIONS A bile acid-independent mechanism is implicated in the effect of meals to raise plasma FGF19 concentrations.

[1]  R. Bergman,et al.  FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.

[2]  A. Honda,et al.  FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels , 2013, Journal of Lipid Research.

[3]  W. Strodel,et al.  A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass , 2013, Diabetes Care.

[4]  J. H. Bekker,et al.  The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. , 2012, Endocrinology.

[5]  Jun Li,et al.  Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1 , 2011, Science Translational Medicine.

[6]  S. Kliewer,et al.  FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. , 2011, Cell metabolism.

[7]  S. Kliewer,et al.  FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis , 2011, Science.

[8]  A. Peterson,et al.  FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways , 2011, PloS one.

[9]  R. Sherwood,et al.  The relationship between postprandial bile acid concentration, GLP‐1, PYY and ghrelin , 2011, Clinical Endocrinology.

[10]  F. G. Benedict,et al.  A biometric study of basal metabolism in man , 2010 .

[11]  M. Mohammadi,et al.  The FGF family: biology, pathophysiology and therapy , 2009, Nature Reviews Drug Discovery.

[12]  S. Strom,et al.  Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression , 2009, Hepatology.

[13]  M. Thorner,et al.  Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. , 2008, The Journal of clinical endocrinology and metabolism.

[14]  T. Lundåsen,et al.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man , 2006, Journal of internal medicine.

[15]  B. Angelin,et al.  Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. , 2005, Gastroenterology.

[16]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[17]  R. Soriano,et al.  Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.

[18]  S. Kliewer,et al.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.

[19]  G. Waeber,et al.  Glucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM , 1993, Diabetes.

[20]  S. Woods,et al.  Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. , 2013, Endocrinology.

[21]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[22]  W. Hopman,et al.  Gallbladder responses to modified sham feeding: effects of the composition of a meal. , 1993, Journal of hepatology.